HIRA to cut off drugs of high cost for the effect.

In the conference to discuss "Introduction of drug economic evaluation system" jointly sponsored by the Health Insurance Review Agency (HIRA) and the Korea Society of health economy and policy on June 14, the HIRA may cut off too expensive drugs for its efficacy or at least reduce its price by evaluating the drug economy applicable to not only new drugs to register but also already available on...